Related Experiment Video
Updated: Jan 17, 2026

An Application for Pairing with Wearable Devices to Monitor Personal Health Status
Published on: February 3, 2022
A Preliminary Study Introducing Electronic Patient-Reported Outcome (ePRO) Using Bring Your Own Device (BYOD) in
Naomi Sugimoto1, Mika Morimasa2, Hidetoshi Misawa3
1PMS Affairs, Pfizer R&D Japan, Shinjuku Bunka Quint Bldg. 3-22-7, Yoyogi, Shibuya-ku, Tokyo, 151-8589, Japan. naomi.sugimoto@pfizer.com.
Electronic patient-reported outcome (ePRO) using bring your own device (BYOD) achieved comparable data completeness to paper methods in a pilot study. This approach is feasible for post-marketing surveillance, though system improvements are suggested.
Area of Science:
- Clinical research methodology
- Health informatics
Background:
- The adoption of electronic patient-reported outcome (ePRO) data collection via bring your own device (BYOD) is increasing in clinical trials.
- A preliminary evaluation was conducted to assess ePRO using BYOD for regulatory-required observational post-marketing surveillance (PMS) in Japan.
Purpose of the Study:
- To evaluate the processes and feasibility of implementing ePRO using BYOD for post-marketing surveillance in Japan.
- To compare data completeness and usability of ePRO with traditional paper-based PRO methods.
Main Methods:
- A multicenter, two-period, two-sequence, cross-over observational study was performed.
- Participants were divided into two groups, one starting with ePRO and the other with paper PRO, for seven days each.
- Usability, implementation, support, and materials for ePRO were assessed via questionnaires.
Main Results:
- Data collection with ePRO was comparable to paper PRO, with no significant differences in data entry status based on sex or age-related missing data trends.
- Over half of participants responded favorably to ePRO system questionnaires.
- Investigators found ePRO system materials useful, but identified areas for improvement.
Conclusions:
- ePRO demonstrated comparable data completeness to paper methods in motivated clinical settings during a two-week pilot.
- Key considerations for implementing ePRO in actual PMS were identified.
- Further evaluation in studies compliant with local regulations is recommended.
More Related Videos
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Bioavailability Study Design: Healthy Subjects Versus Patients
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Holter Monitor: 24-Hour Monitoring

